Stem cell nasal drops for stable vitiligo
Part of Skin clinical trials.
This early-phase trial tests whether nasal drops made from special stem cell particles can help treat stable vitiligo. It is for people with small, stable white patches who have not used other treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 60 years old.
- Your vitiligo has been stable (not spreading or getting worse) for at least 6 months.
- You have at least 3 white patches, and at least 2 of them are larger than a dime (2 cm).
- The total area of white patches is less than 1% of your body (roughly the size of one or two palms).
- You have not used any other vitiligo treatments (like steroid creams, JAK inhibitors, light therapy, or surgery) in the last 3 months, and you agree not to use any during the study.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called ICP-332 for vitiligo that isn't limited to one area (non-segmental). It aims to see if the drug can help restore skin color. The study is for both adults and teenagers who have had vitiligo for at least 3 months with a certain amount of skin affected.
This study tests whether special particles derived from umbilical cord stem cells can help restore skin color in vitiligo (a condition causing loss of skin pigmentation). The treatment is being tested in adults with vitiligo affecting 1–30% of their body.
This trial tests whether taking small doses of steroids by mouth for a few days before and after a skin cell transplant (NCES) can reduce the white halo that sometimes forms around the treated area. It is for people with stable vitiligo on the face or trunk that hasn't responded to creams or light therapy.
This trial tests whether adding short bursts of steroid pills to a skin cell transplant procedure can improve results for people with stable vitiligo on hard-to-treat areas like elbows and knees.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
Hear when a new Stable Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.